BPC-157 is not on the FDA's approved drug list, but the bulk active ingredient is permitted for compounding by a 503A pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act
A 5-minute shot for real, lasting energy
Our study effectively treated OA via a synergistic strategy of anti-senescence and pro-chondrogenesis that may inform the treatment of OA and other degenerative joint diseases
A common question is whether higher-dose injections are safe compared with lower-dose pills
Phase 3: Optimize both (weeks 9-16) Increase AOD 9604 to 300-500mcg daily based on tolerance
There is a pressing need for standardized diagnostics and longitudinal studies to clarify the temporal relationship between microbiome changes and disease onset, as well as to identify reliable microbial or metabolic biomarkers for early detection and targeted intervention (Dai et al., 2024